Pharmaceutical

Pfizer touts positive topline data for RSV vaccine Abrysvo

Abrysvo was found to be safe in immunocompromised adults at risk for developing RSV-associated lower respiratory tract disease.

Aug 13, 2024 - 04:00
Pfizer touts positive topline data for RSV vaccine Abrysvo
Abrysvo was found to be safe in immunocompromised adults at risk for developing RSV-associated lower respiratory tract disease.
Read the original article

Tags:

Previous Article

FDA approves Sandoz’s Enzeevu as Eylea biosimilar saga continues

Next Article

Patient with rare neurodegenerative disorder improves with non-profit’s ASO therapy

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

FDA committee proposes overhaul of perioperative lung cancer trials 

FDA committee proposes overhaul of perioperative lung c...

Jul 28, 2024

China accepts Junshi’s new drug application for NSCLC combo therapy

China accepts Junshi’s new drug application for NSCLC c...

Apr 12, 2023

Opinion: Four communication lessons we learned the hard way during the pandemic

Opinion: Four communication lessons we learned the hard...

Jun 6, 2023